S&P Global Upgrades Cosmo's ESG Rating; Enhances Supplier Sustainability Oversight and Italian Manufacturing Facility Receives EcoVadis Bronze Medal
Sustainability Milestones: Cosmo Pharmaceuticals has improved its S&P Global Corporate Sustainability Assessment score to the 67th percentile, reflecting significant progress in sustainability practices across governance, environment, and social impact.
EcoVadis Recognition: Cosmo SpA, the Italian manufacturing subsidiary, received an EcoVadis Bronze Medal for sustainable manufacturing, scoring 64/100 and ranking above 71% of rated companies, highlighting its strong performance in environmental management and supply-chain sustainability.
Responsible Sourcing Initiative: The company has partnered with EcoVadis to enhance supply-chain transparency and risk management by evaluating suppliers on environmental, social, ethical, and procurement standards.
Future ESG Reporting: Cosmo is committed to strengthening its ESG framework in line with TCFD and CSRD standards, with plans to publish its 2025 ESG Report in early March 2026.
About the author









